⌘K
TECLens
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$9.3M
TECLens develops a non-invasive ophthalmic device that uses corneal cross-linking technology to reshape the cornea for vision correction.
Focus Areas
Ophthalmic
Medical Device
Non-Incisional
Refractive Correction
Corneal Cross-Linking
UV Light
Investors
